FEV1 (% predicted): mean change from baseline · children aged over eight and adults with cystic fibrosis and chronic pulmonary infection with P aeruginosa
Summary of findings: garlic supplementation showed no clear difference in respiratory function change from baseline in % predicted FEV1 compared with placebo (moderate certainty).
1 finding from 1 review
In‐hospital postoperative mortality · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in in‐hospital postoperative mortality compared with placebo (moderate certainty).
1 finding from 1 review
Duration of postoperative mechanical ventilation · Children having heart surgery with cardiopulmonary bypass
1 finding from 1 review
Length of postoperative ICU stay · Children having heart surgery with cardiopulmonary bypass
1 finding from 1 review
Length of postoperative hospital stay · Children having heart surgery with cardiopulmonary bypass
1 finding from 1 review
Mortality within the longest · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in all‐cause mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in cardiovascular mortality at longest compared with placebo (moderate certainty).
1 finding from 1 review
Failure to separate from CPB · Children having heart surgery with cardiopulmonary bypass
Glucocorticoid showed no clear difference in failure to separate from CPB compared with placebo (low certainty).
1 finding from 1 review
Hospital mortality · patients with cardiogenic pulmonary oedema
NPPV may leads to lower HOSPITAL MORTALITY compared with SMC (low certainty).
1 finding from 1 review
ETI RATE · patients with cardiogenic pulmonary oedema
NPPV probably leads to lower ETI RATE compared with SMC (moderate certainty).
1 finding from 1 review
Myocardial infarction · patients with cardiogenic pulmonary oedema
NPPV showed no clear difference in ACUTE MI INCIDENCE compared with SMC (moderate certainty).
1 finding from 1 review
Length of hospital stay · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Duration of ICU stay · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Intolerance to allocated treatment · patients with cardiogenic pulmonary oedema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Mortality (0 to 30 days) · adult cardiac surgical patients
Epidural analgesia showed no clear difference in mortality (0 to 30 days) compared with systemic analgesia (low certainty).
1 finding from 1 review
Myocardial infarction (0 to 30 days) · adults undergoing cardiac surgery without cardiopulmonary bypass
It is very uncertain whether epidural analgesia changes myocardial infarction (0 to 30 days) compared with peripheral nerve blocks (very low certainty).
1 finding from 1 review
Atrial fibrillation or atrial flutter (0 to 2 weeks) · adults undergoing cardiac surgery without cardiopulmonary bypass
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurological complications · adults undergoing cardiac surgery without cardiopulmonary bypass
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of tracheal intubation · adults undergoing cardiac surgery without cardiopulmonary bypass
It is very uncertain whether epidural analgesia changes duration of tracheal intubation compared with peripheral nerve blocks (very low certainty).
1 finding from 1 review